44
Participants
Start Date
January 31, 2015
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
crenolanib
cytarabine
daunorubicin
idarubicin
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
Roswell Park Cancer Institute, Buffalo
Cleveland Clinic, Cleveland
University of Iowa Hospitals and Clinics, Iowa City
University of Texas Southwestern Medical Center, Dallas
City of Hope Medical Center, Duarte
Fred Hutchinson Cancer Research Center, Seattle
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Arog Pharmaceuticals, Inc.
INDUSTRY